NVOX Stock Summary and Trading Ideas (Defiance Daily Target 2X Long Nvo ETF | ARCA:NVOX)

The Defiance Daily Target 2X Long NVO ETF (the "Fund") seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of NOVO Nordisk A/S - ADR (NYSE: NVO) (the "Underlying Security" or "NVO"). NVOX does not invest directly in NOVO. NOVO Nordisk A/S ("Novo Nordisk") is a Danish global pharmaceutical company. Novo Nordisk manufactures and markets pharmaceutical products and services, specifically to provide diabetes care and other chronic conditions like obesity, hemophilia, and growth disorders. It is also involved with hemostasis management, growth hormone therapy, and hormone replacement therapy. The Fund will seek to achieve its objective with respect to Novo Nordisk's American Depositary Receipt (NYSE: NVO).

Defiance Daily Target 2X Long Nvo ETF trades on the ARCA stock market under the symbol NVOX.

As of December 26, 2025, NVOX stock price declined to $23.23 with 488,650 million shares trading.

NVOX has a beta of 2.82, meaning it tends to be more sensitive to market movements. NVOX has a correlation of 0.13 to the broad based SPY ETF.

NVOX has a market cap of $101.70 million. This is considered a Micro Cap stock.

NVOX has underperformed the market in the last year with a return of -76.2%, while the SPY ETF gained +16.0%. In the last 3 month period, NVOX fell short of the market, returning -18.7%, while SPY returned +4.6%. However, in the most recent 2 weeks NVOX has outperformed the stock market by returning +7.7%, while SPY returned +1.5%.

NVOX support price is $22.03 and resistance is $24.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVOX shares will trade within this expected range on the day.